The up-regulation of NCAPG2 in non-small cell lung cancer (NSCLC) cells caused a short survival time, whereas suppressing NCAPG2 expression led to proliferation inhibition and G2/S cycle arrest (Zhan et al., 2017). Here, NCAPG2 is linked to non-small cell lung carcinoma.